Impel Pharmaceuticals Inc

NASDAQ:IMPL  
6.54
+0.32 (+5.14%)
Debt Financing / Related

Impel Neuropharma Announces $100 Mln Royalty And Debt Financing Agreement With Oaktree

Published: 03/17/2022 13:37 GMT
Impel Pharmaceuticals Inc (IMPL) - Impel Neuropharma Announces $100 Million Royalty and Debt Financing Agreement With Oaktree.
Impel Neuropharma Inc - Transaction Provides Immediate, Non-dilutive Capital to Further Support Commercialization of Trudhesa.
Impel Neuropharma Inc - $100 Million in Gross Proceeds to Be Funded at Close, Extending Estimated Corporate Cash Runway Into 2024.